(S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine

Metabolite details

Identifier

SKIVBBIKOOPRPR-UHFFFAOYSA-N

InChI Key

SKIVBBIKOOPRPR-UHFFFAOYSA-N

IUPAC name

2-[(1-methyl-4-oxoimidazolidin-2-ylidene)amino]propanoic acid

Preferred name

(S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine

INN name

—

Synonym

—

ChEBI

CHEBI:178115

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d